Alex Philippidis

RT @GENbio: 🎧GEN's New Episode of Touching Base Is Available! GEN’s @alexwestchester, @xiaofei_lin, @UduakThomas9861, and @CSingleman high…

6June: Hear about the latest patient death in a gene therapy trial, the Boltz-2 open-source tool & more from @GENbio colleagues @CSingleman, @xiaofei_lin, @UduakThomas9861 & me on this latest episode of our "Touching Base" podcast. Download & listen: https://t.co/j5u5cgwGZV

RT @GENbio: Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions” — @KevinADavies & @AlexWestchester report on today’s h…

RT @AIZiadSaliba: @GENbio @KevinADavies @AlexWestchester @US_FDA Impressive FDA dialogue opens doors to international collaboration. Trust…

RT @abscibio: See why we are excited about the potential ABS-101, Absci’s first AI-designed biologic to enter the clinic, has to treat IBD,…

RT @KevinADavies: First Personalized CRISPR Gene Editing Therapy Patient Baby KJ Discharged — excellent piece by @GrinsteinJ on the lates…

2June: How did @Sanofi CEO Paul Hudson describe his company's capacity for additional acquisitions after agreeing to buy @BlueprintMeds for up to $9.5B? My latest for @GENbio: https://t.co/VEDkkhmG5W

SundayBest (Psalm 143: 6-7, in Sunday Orthros): I spread out my hands to you; my soul longs for you like a thirsty land. Lord, hear me quickly; my spirit fails. https://t.co/Iy5xMJrRt3

28May: What does @RocketPharma suspect may have led to the death of a patient dosed with its Danon disease gene therapy candidate RP-A501 in a pivotal trial? And how did three analysts respond to the news? My latest for @GENbio: https://t.co/ZS9DEvl6xs

RT @GENbio: 🎧 Don't miss he latest podcast episode of Touching Base! Customized CRISPR for KJ, @10xGenomics and @illumina Lawsuits, @Regen…

RT @GENbio: 🎧 Customized CRISPR for KJ, @10xGenomics and @illumina Lawsuits, @Regeneron Bags @23andMe In the latest episode of Touching Ba…

SundayBest (Kontakion of Sunday of the Blind Man, Plagal of the First Tone): I come to You, O Christ, as the man blind from birth. With the eyes of my soul blinded, I cry out to You in repentance, "You are the resplendent Light of those in darkness." https://t.co/EUhSWaFe26

RT @GENbio: Don't Miss Alex Philippidis Latest StockWatch! With @inozyme buyout, @BioMarin pursues growth via M&A. Pluse @bluebirdbio shar…

19May: What a day for news... What steps remain before the bankruptcy court signs off on @Regeneron's $256M acquisition of @23andMe? Details in @GENbio: https://t.co/quebFDFHDg

19May: What opportunities, and risks, do analysts see in @BioMarin 's planned acquisition of @inozyme ? Read about $BMRN and $INZY, plus updates on $BLUE, $SEPN, and $URGN in my latest StockWatch for @GENbio: https://t.co/2d8AE48BuO

19May: How much did @10xGenomics disclose it will receive from @bruker and @vizgen_inc in settlements of separate lawsuits? I join colleague and editor @julemieux1 to recap the settlements, in our latest for @GENbio: https://t.co/l8PvtVa5mx